Try our Advanced Search for more refined results

Bio-Rad Laboratories, Inc. et al v. 10X Genomics Inc.

  1. July 27, 2021

    Bio-Rad And 10X Agree To End Patent War

    Biotech rivals 10X Genomics and Bio-Rad Laboratories Inc. said Tuesday that they had reached a deal to end their many legal fights over competing DNA technology, less than a week before the two California companies were set to spar again in front of a jury in Delaware.

  2. June 04, 2021

    Bio-Rad Tries To Keep 10X From Talking Up Pandemic At Trial

    Bio-Rad has told a Massachusetts federal judge that any mention of the ongoing COVID-19 pandemic at next month's jury trial over its patented DNA technology would be "highly inflammatory," accusing 10X of trying to overstate the "alleged importance" of 10X's own scientific research.

  3. February 01, 2021

    Bio-Rad's $35M IP Win Tainted By Falsehoods, 10X Says

    Bio-Rad Laboratories knowingly presented false testimony to a jury to extract a high licensing fee of 15% for DNA-manipulation patents, rival 10X Genomics told a Delaware federal court Friday in unusual post-trial papers seeking to erase a $35 million judgment.

  4. December 15, 2020

    Judge Allows Bio-Rad To Collect $35M IP Judgment

    A Delaware federal judge has ruled that 10X Genomics Inc.'s bid to stop rival Bio-Rad Laboratories Inc. from collecting a $35 million judgment was too late and said 10X's new fraud claims in the patent-infringement fight would likely be "a non-starter."

  5. December 10, 2020

    10X Calls Fraud In Latest Effort To Dodge $24M Jury Verdict

    Bio-Rad Laboratories Inc. hasn't kept its stories straight about how much its patented DNA technology is really worth, rival 10X Genomics Inc. said Thursday in alleging that a Delaware federal jury's nearly $24 million infringement verdict against 10X was obtained through fraud and lies.

  6. July 24, 2019

    Bio-Rad Gets 10X's DNA Products Blocked, Plus $24M Cash

    A Delaware federal judge on Wednesday topped off a $24 million patent infringement verdict against 10X Genomics Inc. by issuing a permanent injunction barring it from selling any product featuring the DNA manipulation method owned by Bio-Rad Laboratories Inc. and the University of Chicago.

  7. July 09, 2019

    Bio-Rad's $24M DNA Patent Win Backed By Evidence: Judge

    A Delaware federal judge on Tuesday upheld a $24 million jury verdict for Bio-Rad in a patent suit over a droplet-based method of manipulating DNA, ruling the jury's decision finding 10X Genomics Inc. had infringed three patents was "supported by substantial evidence." 

  8. November 14, 2018

    Bio-Rad Wins $24M Jury Verdict In 10X Genomics Patent Suit

    A Delaware federal judge on Wednesday ordered 10X Genomics Inc. to pay nearly $24 million to Bio-Rad Laboratories Inc. and the University of Chicago after a jury found that it infringed a droplet-based method of manipulating DNA.

  9. June 27, 2018

    Bio-Rad's IP Suit Over DNA Tech Survives Early Win Bids

    10X Genomics Inc. must face the majority of a patent infringement suit brought by Bio-Rad Laboratories Inc. and the University of Chicago over a droplet-based method of manipulating DNA, with a Delaware federal judge largely denying summary judgment Tuesday.

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!